Fractionated radioimmunotherapy with 90Y-clivatuzumab tetraxetan and low-dose gemcitabine is active in advanced pancreatic cancer: A phase 1 trial Academic Article uri icon

Overview

MeSH Major

  • Deoxycytidine
  • Pancreatic Neoplasms
  • Radioimmunotherapy
  • Yttrium Radioisotopes

abstract

  • Fractionated radioimmunotherapy with (90) Y-hPAM4 and low-dose gemcitabine demonstrated promising therapeutic activity and manageable myelosuppression in patients with advanced pancreatic ductal carcinoma.

publication date

  • November 15, 2012

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4215160

Digital Object Identifier (DOI)

  • 10.1002/cncr.27592

PubMed ID

  • 22569804

Additional Document Info

start page

  • 5497

end page

  • 506

volume

  • 118

number

  • 22